Journal article
Progress in the Management of Pancreatic Neuroendocrine Tumors
Annual review of medicine, Vol.73(1), pp.213-229
01/01/2022
DOI: 10.1146/annurev-med-042320-011248
PMID: 34669433
Abstract
Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of neoplasms that vary in their histology, clinical features, prognosis, and management. The treatment of PNETs is highly dependent on the stage at presentation, tumor grade and differentiation, presence of symptoms from hormonal overproduction or from local growth, tumor burden, and rate of progression. The US Food and Drug Administration has recently approved many novel treatments, which have altered decision making and positively impacted the care and prognosis of these patients. In this review, we focus on the significant progress made in the management of PNETs over the past decade, as well as the active areas of research.
Details
- Title: Subtitle
- Progress in the Management of Pancreatic Neuroendocrine Tumors
- Creators
- Amy Chang - University of MichiganScott K. Sherman - University of IowaJames R. Howe - University of IowaVaibhav Sahai - University of Michigan
- Resource Type
- Journal article
- Publication Details
- Annual review of medicine, Vol.73(1), pp.213-229
- DOI
- 10.1146/annurev-med-042320-011248
- PMID
- 34669433
- NLM abbreviation
- Annu Rev Med
- ISSN
- 0066-4219
- eISSN
- 1545-326X
- Publisher
- Annual Reviews
- Number of pages
- 17
- Language
- English
- Date published
- 01/01/2022
- Academic Unit
- Surgery
- Record Identifier
- 9984322958302771
Metrics
8 Record Views